Outline of infectious disease concepts

Last updated

The following outline is provided as an overview of and topical guide to concepts related to infectious diseases in humans.

Contents

Infection transmission, entry/invasion after evading/overcoming defense, establishment, and replication of disease-causing microscopic organisms (pathogens) inside a host organism, and the reaction of host tissues to them and to the toxins they produce. [1]

Infectious disease illness or disorder when pathogenic (disease-causing) microorganisms, such as bacteria, viruses, fungi, or parasites invade and multiply within the body of a host organism and release toxins, causing various clinical symptoms which can potentially lead to severe health complications or even death. Infectious diseases can be spread, directly or indirectly, from person to person, from animal to animal, or from animals to humans (zoonotic diseases), or through environmental exposure. They can be treated with medical interventions or prevented before they happen. [1]

Determinants

Agent

Infectious agent (also known as pathogen) a biological entity (microscopic or macroscopic) that causes disease or illness in its host by invading and multiplying within the host's body, disrupting its normal physiological functions and leading to clinical symptoms (i.e. an infectious disease).

  • Biofilm - sticky microbial communities adhering to surfaces, facilitating bacterial survival and resistance to treatments.
  • Germ theory of disease - paradigm that microorganisms are the principal causative agents of infectious diseases. [1]
  • Infectivity - ability of a pathogen to establish itself and cause infection in a susceptible host
    • Infectious dose - quantity of pathogen required to cause infection in a host organism.
  • Pathogenicity - ability of a pathogenic microorganism to cause disease in a host organism.
    • Attack rate proportion of a population of susceptible individuals who get infected and develop illness during an outbreak over a certain period of time. [2]
  • Quorum sensing - Cell-to-cell communication system used by some pathogenic bacteria, potentially triggering virulence factor production.
  • Virulence - degree of pathogenicity, measured by the severity of an infectious disease based on damage caused and the host's immune response.
    • Endotoxin - toxin released from the outer membrane of certain gram-negative bacteria, triggering inflammation.
    • Exotoxin - toxin secreted by bacteria into the surrounding environment (damaging host tissue)
    • Case fatality rate - proportion (percentage) of individuals diagnosed with a specific infectious disease who die from it.
    • Virulence factors - molecule or characteristic possessed or structure produced by pathogens that increase their ability to cause disease in a host organism.
  • Antimicrobial resistance (including antibiotic resistance) - ability of microorganisms to resist the effects of medications designed to kill or inactivate them. [1]
    • Drug resistance - reduction in effectiveness of a medication such as an antimicrobial or an antineoplastic in treating a disease.
    • Horizontal gene transfer - Transfer of genetic material between different organisms of the same generation, allowing them to acquire new traits, including resistance to antibiotics.
    • Multidrug-resistant bacteria/Superbug - bacteria resistant to multiple classes of antibiotics, with limited treatment options.
  • Host tropism - preference of a pathogen for a particular host species, cell type, or tissue.

There are mainly seven types of pathogenic microorganisms: viruses, bacteria, fungi, protozoa, helminths, other parasites and abnormal proteins called prions. [3]

  • Bacteria microscopic single-celled organisms lacking a nucleus, some of which can cause infections in humans. [1]
    • Bacterial diseases diseases caused by bacteria.
    • Bacteriology study of bacteria, their characteristics, growth, and role in infectious diseases.
  • Viruses - microscopic pathogens consisting of genetic material surrounded by a protein coat, requiring living cells of host organisms to replicate. [1]
    • Viral disease diseases caused by viruses.
    • Virology study of viruses, their structure, replication, and role in viral diseases.
  • Prions infectious agents composed solely of misfolded proteins, causing neurodegenerative disorders. [1]
    • Prion diseases progressive, incurable, and fatal neurodegenerative diseases associated with prions, affecting humans and animals.
  • Fungi eukaryotic spore-forming organisms distinct from plants, animals, and bacteria including single-cell yeasts and multi-cell molds, some of which can cause infections in humans. [1]
    • Fungal infection/Mycosis/Fungal disease infection (and infectious disease) caused by fungi.
    • Mycology study of fungi, their growth, and their role in fungal infections.
  • Parasite - organism benefitting at the cost of a host organism. [1]
    • Parasitic disease  – infectious disease caused or transmitted by a parasite
    • Parasitology study of parasites, their life cycles, and the diseases they cause in humans and animals.
    • Protozoa single-celled eukaryotic organisms that can live as parasites within a host. [1]
    • Helminths macroscopic parasitic worms that can live in different organs and tissues of their host
      • Helminthiasis/Worm infection - parasitic worm infections caused by various helminths (i.e. roundworms, tapeworms, and flukes) residing in different organs and tissues, causing discomfort, nutritional deficiencies, and potentially organ damage.
    • Infestation - overgrowth of parasites (like lice, mites, or worms) on or within a host, often causing irritation, discomfort, and potential secondary infections due to scratching or burrowing.
  • Insect vectors - usually an arthropod such as flea, tick or mosquito carrying a pathogen from one host to another. [1]

Host

Host a living organism, typically a human or animal, that harbors a pathogenic microorganism, providing the environment and resources necessary for it to survive, grow, and potentially reproduce or multiply. There is a symbiotic relationship between the two organisms, which can be commensal (mutually beneficial), but in the case of infectious diseases, harmful for the host. [1]

  • Burn causing damage to the skin and underlying tissues, compromising the body's primary defense barrier and increasing susceptibility to infections.
  • Comorbidity presence of one or more additional medical conditions that can increase susceptibility to infections.
  • Diabetes Diabetes impairs immune function and causes poor circulation, increasing susceptibility to infections and complicating healing.
  • Host–pathogen interaction host's immune defenses and the pathogen's strategies to invade and survive, determining the outcome and severity of infections
  • Immune response body's defense mechanism to recognize, fight, and eliminate pathogens, which influences the susceptibility, severity, and resolution of infections.
    • Immunodeficiency weakened or compromised immune system that reduces the body's ability to effectively fight off pathogens, leading to increased susceptibility and severity of infections.
    • Immunosuppression deliberate reduction or impairment of the immune system's function due to medical treatments or conditions, causing increased vulnerability to infections.
  • Microbiome health balance and diversity of the microbial communities in the body, influencing the immune response and overall susceptibility to infections.
  • Opportunistic infection infection caused by pathogens that take advantage of a weakened or compromised immune system.
  • Risk of infection Likelihood of contracting an infection, which is influenced by a host's inherent susceptibility (age, immune status, genetics) or external exposures (behavior, environment).
  • Susceptible individual individual lacking immunity and at risk of infection by a specific pathogen.
    • Age (Immunosenescence) age-related decline in the immune system's function, making older adults more susceptible to infections.
    • Sex/Gender susceptibility to infection due to hormonal differences, immunological variations and differences in behavioral patterns between males and females.
    • Nutrition status nutrient and micronutrient deficiencies increases susceptibility to infections.
    • Vaccination status vaccination can lower the risk of infection by preparing the immune system to recognize and efficiently combat specific pathogens.
    • Genetic predisposition Variations in immune Genes, susceptibility genes and major histocompatibility complex (MHC) genes and genetic predisposition to certain chronic inflammatory disease, contributing to weakening of the immune system.
      • Immunogenetics field investigating the complex interplay between genes and the immune system affecting infection risk.
    • Behavioral/lifestyle factors
      • Smoking weakens the immune system and damages lung tissue, making individuals more susceptible to respiratory infections.
      • Sleep deprivation weakens the immune system's ability to fight off pathogens.
      • Poor oral hygiene creates a reservoir for bacteria that can potentially enter the bloodstream and cause infections elsewhere in the body.
      • Physical inactivity weakens immune function, reduces lung capacity, increases risk of chronic diseases and reduces blood flow, making a person more susceptible to infections.
      • Substance abuse Drug and alcohol use can impair the immune system and increase susceptibility to infections.
      • Unprotected/unsafe sex increases the risk of contracting sexually transmitted infections.
    • Pregnancy physiological changes, hormonal changes and immunological changes occurring in the mother's body and not meeting the nutritional demands can lead to infections.
    • Stress levels Chronic stress can suppress the immune system, potentially making the body more vulnerable to infection.

Environment

Environment the external conditions and factors such as climate, sanitation, human behavior and living conditions that influence the spread, survival, and transmission of pathogens and the risk of infectious diseases.

  • Access to water and sanitation Access to clean, safe water and proper sanitation facilities for waste disposal (toilets, latrines) are crucial to prevent waterborne and fecal-oral transmission of pathogens.
  • Air quality poor air quality with high levels of particulate matter (PM) can irritate the respiratory tract and potentially increase susceptibility to respiratory infections; chronic inflammation caused by exposure to pollutants weaken the immune system.
  • Biodiversity loss disrupts the natural balance that can keep pathogen populations in check, force wildlife into closer contact with humans and domestic animals leading to zoonosis, eliminate reservoir hosts leading to the emergence of new pathogens in the remaining wildlife populations and forcing the pathogen to seek new hosts, including humans.
  • Climate change expands the geographic range of insect vectors, favors the survival and reproduction of some pathogens, disrupts ecosystems, worsens existing health problems, etc. impacting in complex ways and making people more susceptible to infections.
  • Climate zones
  • Commerce
  • Deforestation
  • Ecology
  • Humidity
  • Injection drug use
  • Natural disaster
  • Poultry and livestock
  • Poverty
  • Travel
  • Urbanization
  • Vector control
  • War and conflict

Transmission

Transmission the process by which an infectious agent is spread from one host (an infected person) or environment (a reservoir) to another susceptible host person, facilitating the spread of disease.

Basic concepts

  • Asymptomatic carrier individual harboring a pathogen without showing symptoms (subclinical infection) and still capable of transmitting it to others.
  • Chain of infection sequential steps or process required for an infectious agent to pass from a source host to a susceptible host.
  • Fomite inanimate object contaminated with infectious agents facilitating their transmission between individuals/hosts.
  • Host organism providing shelter and sustenance to a pathogen, helping to survive and potentially replicate to cause health problems.
  • Incubation period time interval between exposure to a pathogen and the onset of clinical symptoms. [1]
  • Index case/Patient zero first identified case in an outbreak investigation, serving as a guide to public health interventions.
  • Infectious period time interval during which an infected individual can transmit the pathogen to other susceptible hosts.
  • Latent period time interval between exposure to a pathogen and when the individual/host becomes infectious, capable of transmitting pathogens.
  • Natural reservoir animal population or environment in which a pathogen normally lives and multiplies and can be transmitted directly or indirectly to humans.
  • Opportunistic infection infection caused by otherwise harmless organisms, taking advantage of a weakened immune system, thus becoming pathogens.
  • Silent/Subclinical/Asymptomatic infection infection with no apparent noticeable signs or symptoms but still capable of spreading, possibly due to a weak immune response or the nature of the pathogen.
  • Superinfection secondary infection occurring on top of a pre-existing one, often with a different pathogen and potentially leading to complex clinical presentations and treatment challenges.
  • Super-spreader infected individual transmitting a pathogen to a disproportionately large number of others (secondary cases) compared to others in an outbreak.
  • Viral load quantity of viral particles in a given volume of (typically per milliliter of) a patient's blood or other body fluids.
  • Window period time interval between exposure to an infection and the reliable detection (by a diagnostic test) of the presence of the pathogen or its specific antibodies in the body.

Modes

Transmission mode the mechanism through which an infectious agent travels from a source (an infected host or a reservoir) to a new susceptible host.

Endogenous

Endogenous transmission the spread of infectious agents within a single host organism, typically from their normal habitat in one part of the body to a new location within the body, rather than between individuals.

Exogenous

Exogenous transmission the transfer and spread of infectious agents between different individuals or from an external source to a host organism.

Cross-species

Cross-species transmission (or host jump) the transmission of infectious agents from one species (original animal reservoir) to a new one, potentially leading to infections in the recipient species.

  • Spillover infection cross-species transmission of pathogens from a domestic or wildlife animal reservoir to a new human host.
  • Vector organism, typically an insect or arachnid, that transmits pathogens from an infected host to a susceptible host individual.
  • Zoonosis infectious disease transmissible from animals to humans.
  • Reverse zoonosis transmission of pathogens from humans to infect animals.
Human-to-human / Cross-infection

Human-to-human transmission (also known as cross-infection) direct or indirect transmission of infectious agents from one individual to another, leading to the spread of disease within a population.

  • Contagious disease  – Infectious disease readily spread by pathogen transmission
    • Contagion disease-causing infectious agent spread by direct or indirect contact. [1]
  • Source
    • Community-acquired
    • Nosocomial/Hospital-acquired infection An infection occurring in a patient within a hospital or a healthcare in a hospital or other healthcare facility, which was not present or incubating at the time of admission, and often associated with invasive procedures or compromised immune states. [4]
    • Iatrogenic/Medical care  – Causation of harm by any medical activity
  • Generational difference
  • Breakthrough infection  – Infection following vaccine administration
Environment-to-human
Routes

Routes of transmission specific pathways through taken by infectious agents to travel from one infected host or reservoir to a new host.

Respiratory
Linked to Vascular system (Blood vessels)
Gastrointestinal (Alimentary canal)
Cutaneous (Skin)
Genitourinary
Trans-placental
  • Prenatal
Cervico-vaginal
  • Perinatal
Other

Modelling

Mathematical modelling of infectious disease mathematical equations, tools and simulations to represent the dynamics of disease transmission within a population in order to understand and predict them for disease control and public health decision-making.

  • Agent-based model Simulation of individual agent (human or animal) behavior and interactions within a defined environment to understand disease spread dynamics.
  • Animal disease model Mathematical model used in veterinary epidemiology to understand zoonotic disease spreading dynamics in animal populations and predict zoonotic spillover (animal to human transmission).
  • Attack rate proportion of a population of susceptible individuals who get infected and develop illness during an outbreak over a certain period of time. [2]
  • Basic reproduction number Average expected number of secondary cases infected by a single primary case in a completely susceptible population, useful for assessing epidemic potential.
  • Compartmental models in epidemiology Mathematical models that group individuals of a population into compartments based on infection status (such as susceptible, infected, recovered) to simulate disease dynamics and transmission patterns over time.
  • Critical community size Minimum population size needed for a disease to persist indefinitely within a community without new introductions, influenced by factors like transmission dynamics and immunity.
  • Force of infection Rate at which susceptible individuals acquire infection from infectious individuals, used to model incidence rate (number of infected individuals) and transmission dynamics.
  • Herd immunity Indirect protection of susceptible individuals from infectious diseases when a large proportion of a population becomes immune, either through vaccination or prior infection, reducing overall transmission risk.
  • Infection rate Rate at which new infections occur within susceptible individuals over a defined period.
  • Machine learning techniques enabling computers to analyze large datasets and identify patterns in disease spread, thus learning to forecast and detect disease outbreak and improve response strategies.
  • Multiplicity of infection Number of different pathogen strains (viral particles/genomes) infecting a single host at the same time, influencing disease severity, transmission dynamics, and evolutionary pathways.
  • Serial interval Time between symptom onset in a primary case and symptom onset in a secondary case infected by the primary case, useful for understanding disease spread patterns and assessing control measures.
  • WAIFW matrix (Who acquires infection from Whom, At what rate, For how long, and With what consequences) mathematical framework/matrix to quantify and summarize key transmission parameters for a disease, such as contact rates and probabilities of infection.

Occurrence in population

  • Disease cluster grouping of cases of a disease occurring closely in a specific time and place, suggesting possible local transmission.
  • Endemic constant presence of a disease within a specific geographic area or population at a predictable baseline level. [1]
  • Epidemic sudden, unexpected increase in the number of cases of a disease in a specific population and geographic area. [1]
    • Epidemic curve graphical representation of the rise, peak, and decline of the number of cases of an epidemic disease over time.
    • Farr's laws principles describing the relationship between population density, poverty, and the occurrence of infectious diseases.
  • Holoendemic highly prevalent and constantly present disease occurrence in a population or geographic area, affecting most individuals from an early age.
  • Hyperendemic consistently and persistently high incidence and/or prevalence of disease occurrence within a particular population or geographic area, equally affecting all age groups.
  • Incidence rate of new cases of a disease occurring in a specific population within a defined time period, typically expressed per 1,000 or 100,000 individuals.
  • Inequality in disease disparities in the burden (distribution and impact) of infectious diseases among different population groups, often due to social determinants of health.
  • Mesoendemic moderate level of constant disease prevalence within a specific geographic area or population.
  • Disease outbreak sudden unexpected increase in the occurrence of the cases of a particular disease cases for a given time period and a specific geographical area. [1]
  • Pandemic widespread epidemic, often affecting multiple countries or continents and involving a large number of people. [4]
  • Prevalence proportion of individuals in a population affected by a disease at a specific point in time.
  • Seasonality fluctuation in disease occurrence in different seasons or times of the year, often linked to environmental factors.
  • Geographic distribution spatial pattern of how disease cases are located and spread across different regions.
  • Sporadic scattered, irregular occurrence of disease cases without any recognizable pattern in space and time, often without any common source of infection.
  • Syndemic co-occurrence and interaction of two or more diseases or health conditions in individuals or a population, exacerbating their negative health outcomes.
  • Twindemic simultaneous occurrence of two epidemics, where two infectious diseases concurrently circulate in a population, potentially straining public health resources and increasing healthcare burden.

Anatomical location

The specific area or organ within the body where pathogenic microorganisms invade and proliferate, leading to localized or systemic disease.

Prevention and control measures

Infection prevention and control strategies, measures and practices designed and implemented to prevent the spread of infectious diseases within healthcare settings and communities, reducing the risk of infections among patients, healthcare workers, and the general population.

Pharmaceutical

Pharmaceutical prevention and control Use of medications, vaccines, and other pharmaceutical interventions to prevent the spread of infectious diseases, treat infected individuals, and manage outbreaks within populations.

  • Antibiotic medication used to prevent and treat bacterial infections by killing or inhibiting bacteria. [1]
    • prophylactic antibiotic administration of antibiotics to an uninfected individual to prevent the development of an infection, typically before a surgical procedure or in individuals at high risk of infection
  • Antifungal medication used to treat fungal infections.
  • Anthelmintic medication used to treat parasitic worm infections.
    • Ascaricide medication used to specifically treat roundworms.
  • Antimicrobial substance that kills, reduces or inhibits the growth of microorganisms.
    • Antimicrobial stewardship strategies to ensure appropriate and effective use of antimicrobial agents to prevent microbial resistance.
  • Antiseptic Chemical substance applied to skin or surface to reduce pathogens and prevent infection, but not strong enough to sterilize.
  • Antiviral Medication to treat or prevent viral infections.
  • Asepsis Techniques and practices to prevent contamination in healthcare settings and maintain sterility.
  • Combination therapy use of multiple medications (multiple active ingredients) simultaneously to treat a single disease, enhancing therapeutic efficacy and reducing the risk of drug resistance.
  • Pharmacovigilance / Drug safety - science and activities involved in the monitoring, detection, assessment, understanding, and prevention of adverse effects or any other drug-related problems to secure their safety and ensure that potential benefits outweigh the risks.
  • Immunization process of strengthening immune response and increase protection against infectious diseases by receiving vaccines. [1]
  • Immunotherapy treatment boosting the body's immune response against disease.
  • Inoculation introduction of a pathogen or antigen into the body to stimulate immunity.
  • Phage therapy treatment using bacteriophage viruses that infect and kill bacteria to combat bacterial infections.
  • Pre-exposure prophylaxis taking medication taken before potential exposure to prevent infectious disease.
  • Post-exposure prophylaxis taking medication taken after potential exposure to prevent infectious disease.
  • Drug repositioning use of existing medications for new indications or purposes not initially intended, including treating infections.
  • Vaccine biological preparation (usually containing weakened or inactive pathogens) to stimulate the immune system to fight against future infection. [1]
    • Vaccination administration of a vaccine to stimulate the immune system and prevent future infection.
    • Vaccine efficacy/effectiveness - measurement of the ability of a vaccine to produce desired outcome (protection of individuals or populations from a specific disease) in controlled conditions/real-world settings.
    • Booster dose additional dose of a vaccine to enhance or prolong immunity or to strengthen waning immunity.
    • Vaccine resistance ability of a pathogen to evade the protective effects of a vaccine, potentially leading to breakthrough infections.
    • Vaccine-preventable disease disease preventable by vaccination.
    • Ring vaccination strategy of targeted vaccination of close contacts of infected individuals to prevent further spread and control outbreaks.

Non-pharmaceutical

Non-pharmaceutical intervention strategies and measures implemented to stop the spread of infection without relying on medication or pharmaceutical products.

  • Contact tracing systematically identifying, assessing and managing individuals potentially exposed to infectious disease through contact with an infected person, in order to monitor and interrupt transmission chains.
  • Cordon sanitaire Emergency quarantine measure restricting movement into and out of a defined geographic area to contain the spread of infectious diseases.
  • Disease surveillance Continuous, systematic monitoring, collection, analysis, and interpretation of disease-related data to identify trends and inform public health interventions.
  • Disinfection use of germicidal chemical agents or physical methods to inactivate, eliminate or reduce harmful microbes on surfaces of inanimate objects, preventing further transmission.
  • Flattening the curve public health strategy aimed at slowing the spread of an infectious disease over time to reduce the peak number of cases, thus mitigating strain on healthcare systems so that they are not overwhelmed.
  • Hygiene practices that promote cleanliness and other sanitary measures to prevent the spread of pathogens.
    • Food hygiene scientific principles and practices related to the handling, preparation, and storage of food to ensure food safety and minimize foodborne illness risk.
    • Hand washing cleaning hands with soap and water or hand sanitizer to remove dirt, germs, and other contaminants to prevent or reduce infectious disease transmission.
    • Gloves Disposable protection worn on hands during medical examinations and procedures to protect both the patient and healthcare provider from cross-contamination and infection by providing a physical barrier for hands, minimizing contact with infectious material.
  • Isolation separation of individuals infected with a contagious disease from healthy populations to prevent infectious disease spread.
    • Barrier nursing outdated term referring to nursing practices that create a barrier between infectious patients and other patients or healthcare workers to prevent infection spread.
  • Stay-at-home order/Lockdown restriction on population movement requiring individuals to remain at home except for essential activities to limit infectious disease spread.
  • Notifiable disease disease that, by law, must be reported to public health authorities upon diagnosis due to its potential to cause outbreaks and public health emergencies.
  • Protective sequestration public health practice of isolating a group of people or a community potentially exposed to a disease for monitoring and prevention of disease spread.
  • Public health science and practice of strategies to protect and improve the health of populations through education, policy making, and research for disease and injury prevention.
    • Community health services health services designed to improve the health and well-being of community members by providing accessible healthcare, education, and preventive measures.
    • Health communication study and application of disseminating health information dissemination and promoting health literacy to educate and empower individuals and communities about health.
    • Health education Educational programs and initiatives aimed at raising awareness, disseminating knowledge, building skills and influencing attitudes and behaviors so that people can make informed decision about health and wellness.
  • Outbreak response coordinated strategies and interventions to detect, control, contain and mitigate the impact of a disease outbreak in a community or region.
  • Quarantine restriction of movement and activities of individuals with symptoms of potential exposure to a contagious infetious disease to prevent further spread during the incubation period.
  • Respiratory source control Implementation of measures like masking to capture respiratory droplets and aerosols in order to prevent or reduce airborne transmission of respiratory pathogens.
    • N95 respirator protective mask designed to fit very closely to the face and provide protection against at least 95% of very small, airborne particles (dust, microbes, pollutants, etc.) less than 0.3 microns in diameter.
    • Surgical mask loose-fitting device covering the nose and mouth that primarily protects the wearer from inhaling infectious respiratory droplets and aerosols in medical and public settings.
    • Personal protective equipment Equipment such as masks, gloves, gowns, and face shields worn by healthcare workers or others at risk to shield them from exposure to infectious agents or hazardous materials.
  • Safe sex sexual practices that minimize the risk of contracting sexually transmitted infections, including the use of condoms and engaging in mutually monogamous relationships.
  • Sanitation Measures and practices to maintaining hygienic living conditions through proper waste management, clean water access, and sewage disposal to prevent disease spread.
  • Screening Brief medical evaluations and tests to detect the early signs of a disease, often administered to asymptomatic individuals.
  • Social distancing Public health measure to maintain physical distance between people to reduce the chance of respiratory transmission of infectious diseases in crowded settings.
  • Standard infection control precautions fundamental infection prevention and control practices to be adopted by staff in healthcare settings, irrespective of patient's infectious status. [4]
  • Sterilization process of destroying infectious agents (as well as all other life forms) from a surface, fluid, or biological medium by using heat, chemicals, irradiation, high pressure, filtration, or a combination of these methods. [1]
  • Transmission-based precautions Additional or tailored infection control measures based on the specific mode or epidemiology of disease transmission.
  • Travel restrictions Policies and regulations that limit or restrict the movement of people across regions or countries to control the spread of infectious diseases.
  • Universal precautions Approach in which all human blood and certain bodily fluids are treated potentially infectious, requiring healthcare workers to wear PPE all the time.
  • Vector control Strategies to reduce or eliminate populations of animals and insects that can transmit diseases to humans.
  • Wastewater surveillance Monitoring and analysis of wastewater to detect and track the presence of specific infectious agents to identify trends in disease prevalence or to provide early warning of disease outbreaks
  • Zoning Designating clean and dirty areas to prevent contaminated objects from being placed in a clean area and creat cross-contamination.

Emerging infectious disease

Emerging infectious disease diseases caused by newly identified or reemerging infectious agents that have recently rapidly increased in incidence or geographic range, posing a potentially significant threat to public health in the near future. [5]

Miscellaneous concepts

History of infectious diseases

Individual diseases

People

  • Alexander Fleming  – Scottish physician and microbiologist (1881–1955)
  • Maurice Hilleman  – American vaccinologist (1919–2005)
  • Edward Jenner  – English physician and pioneer of vaccines (1749–1823)
  • Robert Koch  – German physician and bacteriologist (1843–1910)
  • Louis Pasteur  – French chemist, pharmacist and microbiologist (1822–1895)
  • Jonas Salk  – American inventor of the polio vaccine (1914–1995)
  • Ignaz Semmelweis  – Early pioneer of antiseptic procedures
  • John Snow  – English epidemiologist and physician (1813–1858)
  • Israel Jacob Kligler  – microbiologist (1888-1944)

Major epidemics and pandemics

Other

Related Research Articles

A human pathogen is a pathogen that causes disease in humans.

A zoonosis or zoonotic disease is an infectious disease of humans caused by a pathogen that can jump from a non-human vertebrate to a human. When humans infect non-humans, it is called reverse zoonosis or anthroponosis.

<span class="mw-page-title-main">Infection</span> Invasion of an organisms body by pathogenic agents

An infection is the invasion of tissues by pathogens, their multiplication, and the reaction of host tissues to the infectious agent and the toxins they produce. An infectious disease, also known as a transmissible disease or communicable disease, is an illness resulting from an infection.

<span class="mw-page-title-main">Epidemic</span> Rapid spread of disease affecting a large number of people in a short time

An epidemic is the rapid spread of disease to a large number of hosts in a given population within a short period of time. For example, in meningococcal infections, an attack rate in excess of 15 cases per 100,000 people for two consecutive weeks is considered an epidemic.

In biology, immunity is the state of being insusceptible or resistant to a noxious agent or process, especially a pathogen or infectious disease. Immunity may occur naturally or be produced by prior exposure or immunization.

<span class="mw-page-title-main">Asymptomatic carrier</span> Organism which has become infected with a pathogen but displays no symptoms

An asymptomatic carrier is a person or other organism that has become infected with a pathogen, but shows no signs or symptoms.

In medicine, public health, and biology, transmission is the passing of a pathogen causing communicable disease from an infected host individual or group to a particular individual or group, regardless of whether the other individual was previously infected. The term strictly refers to the transmission of microorganisms directly from one individual to another by one or more of the following means:

Tick-borne diseases, which afflict humans and other animals, are caused by infectious agents transmitted by tick bites. They are caused by infection with a variety of pathogens, including rickettsia and other types of bacteria, viruses, and protozoa. The economic impact of tick-borne diseases is considered to be substantial in humans, and tick-borne diseases are estimated to affect ~80 % of cattle worldwide. Most of these pathogens require passage through vertebrate hosts as part of their life cycle. Tick-borne infections in humans, farm animals, and companion animals are primarily associated with wildlife animal reservoirs. Many tick-borne infections in humans involve a complex cycle between wildlife animal reservoirs and tick vectors. The survival and transmission of these tick-borne viruses are closely linked to their interactions with tick vectors and host cells. These viruses are classified into different families, including Asfarviridae, Reoviridae, Rhabdoviridae, Orthomyxoviridae, Bunyaviridae, and Flaviviridae.

<i>Francisella tularensis</i> Species of bacterium

Francisella tularensis is a pathogenic species of Gram-negative coccobacillus, an aerobic bacterium. It is nonspore-forming, nonmotile, and the causative agent of tularemia, the pneumonic form of which is often lethal without treatment. It is a fastidious, facultative intracellular bacterium, which requires cysteine for growth. Due to its low infectious dose, ease of spread by aerosol, and high virulence, F. tularensis is classified as a Tier 1 Select Agent by the U.S. government, along with other potential agents of bioterrorism such as Yersinia pestis, Bacillus anthracis, and Ebola virus. When found in nature, Francisella tularensis can survive for several weeks at low temperatures in animal carcasses, soil, and water. In the laboratory, F. tularensis appears as small rods, and is grown best at 35–37 °C.

<span class="mw-page-title-main">Natural reservoir</span> Type of population in infectious disease ecology

In infectious disease ecology and epidemiology, a natural reservoir, also known as a disease reservoir or a reservoir of infection, is the population of organisms or the specific environment in which an infectious pathogen naturally lives and reproduces, or upon which the pathogen primarily depends for its survival. A reservoir is usually a living host of a certain species, such as an animal or a plant, inside of which a pathogen survives, often without causing disease for the reservoir itself. By some definitions a reservoir may also be an environment external to an organism, such as a volume of contaminated air or water.

An emergent virus is a virus that is either newly appeared, notably increasing in incidence/geographic range or has the potential to increase in the near future. Emergent viruses are a leading cause of emerging infectious diseases and raise public health challenges globally, given their potential to cause outbreaks of disease which can lead to epidemics and pandemics. As well as causing disease, emergent viruses can also have severe economic implications. Recent examples include the SARS-related coronaviruses, which have caused the 2002–2004 outbreak of SARS (SARS-CoV-1) and the 2019–2023 pandemic of COVID-19 (SARS-CoV-2). Other examples include the human immunodeficiency virus, which causes HIV/AIDS; the viruses responsible for Ebola; the H5N1 influenza virus responsible for avian influenza; and H1N1/09, which caused the 2009 swine flu pandemic. Viral emergence in humans is often a consequence of zoonosis, which involves a cross-species jump of a viral disease into humans from other animals. As zoonotic viruses exist in animal reservoirs, they are much more difficult to eradicate and can therefore establish persistent infections in human populations.

Bovine alphaherpesvirus 1 (BoHV-1) is a virus of the family Herpesviridae and the subfamily Alphaherpesvirinae, known to cause several diseases worldwide in cattle, including rhinotracheitis, vaginitis, balanoposthitis, abortion, conjunctivitis, and enteritis. BoHV-1 is also a contributing factor in shipping fever, also known as bovine respiratory disease (BRD). It is spread horizontally through sexual contact, artificial insemination, and aerosol transmission and it may also be transmitted vertically across the placenta. BoHV-1 can cause both clinical and subclinical infections, depending on the virulence of the strain. Although these symptoms are mainly non-life-threatening it is an economically important disease as infection may cause a drop in production and affect trade restrictions. Like other herpesviruses, BoHV-1 causes a lifelong latent infection and sporadic shedding of the virus. The sciatic nerve and trigeminal nerve are the sites of latency. A reactivated latent carrier is normally the source of infection in a herd. The clinical signs displayed are dependent on the virulence of the strain. There is a vaccine available which reduces the severity and incidence of disease. Some countries in Europe have successfully eradicated the disease by applying a strict culling policy.

Avipoxvirus is a genus of viruses within the family Poxviridae. Poxviridae is the family of viruses which cause the afflicted organism to have poxes as a symptom. Poxviruses have generally large genomes, and other such examples include smallpox and monkeypox. Members of the genus Avipoxvirus infect specifically birds. Avipoxviruses are unable to complete their replication cycle in non-avian species. Although it is comparably slow-spreading, Avipoxvirus is known to cause symptoms like pustules full of pus lining the skin and diphtheria-like symptoms. These diphtheria-like symptoms might include diphtheric necrotic membranes lining the mouth and the upper respiratory tract. Like other avian viruses, it can be transmitted through vectors mechanically such as through mosquitoes. There is no evidence that this virus can infect humans.

<span class="mw-page-title-main">Medical microbiology</span> Branch of medical science

Medical microbiology, the large subset of microbiology that is applied to medicine, is a branch of medical science concerned with the prevention, diagnosis and treatment of infectious diseases. In addition, this field of science studies various clinical applications of microbes for the improvement of health. There are four kinds of microorganisms that cause infectious disease: bacteria, fungi, parasites and viruses, and one type of infectious protein called prion.

<span class="mw-page-title-main">Introduction to viruses</span> Non-technical introduction to viruses

A virus is a tiny infectious agent that reproduces inside the cells of living hosts. When infected, the host cell is forced to rapidly produce thousands of identical copies of the original virus. Unlike most living things, viruses do not have cells that divide; new viruses assemble in the infected host cell. But unlike simpler infectious agents like prions, they contain genes, which allow them to mutate and evolve. Over 4,800 species of viruses have been described in detail out of the millions in the environment. Their origin is unclear: some may have evolved from plasmids—pieces of DNA that can move between cells—while others may have evolved from bacteria.

<span class="mw-page-title-main">Influenza</span> Infectious disease

Influenza, commonly known as the flu, is an infectious disease caused by influenza viruses. Symptoms range from mild to severe and often include fever, runny nose, sore throat, muscle pain, headache, coughing, and fatigue. These symptoms begin one to four days after exposure to the virus and last for about two to eight days. Diarrhea and vomiting can occur, particularly in children. Influenza may progress to pneumonia from the virus or a subsequent bacterial infection. Other complications include acute respiratory distress syndrome, meningitis, encephalitis, and worsening of pre-existing health problems such as asthma and cardiovascular disease.

<span class="mw-page-title-main">Airborne transmission</span> Disease transmission by airborne particles

Airborne transmission or aerosol transmission is transmission of an infectious disease through small particles suspended in the air. Infectious diseases capable of airborne transmission include many of considerable importance both in human and veterinary medicine. The relevant infectious agent may be viruses, bacteria, or fungi, and they may be spread through breathing, talking, coughing, sneezing, raising of dust, spraying of liquids, flushing toilets, or any activities which generate aerosol particles or droplets.

In biology, a pathogen, in the oldest and broadest sense, is any organism or agent that can produce disease. A pathogen may also be referred to as an infectious agent, or simply a germ.

This glossary of virology is a list of definitions of terms and concepts used in virology, the study of viruses, particularly in the description of viruses and their actions. Related fields include microbiology, molecular biology, and genetics.

<span class="mw-page-title-main">Glossary of the COVID-19 pandemic</span> Glossary article for the COVID-19 pandemic

The COVID-19 pandemic has created and popularized many terms relating to disease and videoconferencing.

References

  1. 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 "Glossary". What you need to know about Infectious Disease. National Academy of Sciences. Retrieved June 7, 2024.
  2. 1 2 "Comprehensive Glossary for Infectious Disease Modelling". National Collaborating Centre for Infectious Diseases. Retrieved June 8, 2024.
  3. "Types of Microbes". What you need to know about Infectious Disease. National Academy of Sciences. Retrieved June 7, 2024.
  4. 1 2 3 4 5 6 "Glossary". National Infection Prevention and Control Manual (UK). Retrieved June 7, 2024.
  5. Institute of Medicine (US) Forum on Emerging Infections (2001), "APPENDIX A, Glossary and Acronyms", in Davis JR; Lederberg J (eds.), Emerging Infectious Diseases from the Global to the Local Perspective: A Summary of a Workshop of the Forum on Emerging Infections, Washington (DC): National Academies Press (US)